- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
ZERO-End Prostate Cancer
ZERO – The End of Prostate Cancer is the leading national nonprofit organization with the mission to end prostate cancer. ZERO advances research, encourages action, and provides education and support to men and their families through our patient-centric programs. ZERO's premier activities include the ZERO Prostate Cancer Run/Walk, America’s largest men’s health event series. We are a 501c3 philanthropic organization recognized with four stars out of four stars by Charity Navigator, accredited by the Better Business Bureau, and 97 cents of every dollar donated goes to research and programs. For more information, visit www.zerocancer.org.
Latest from ZERO-End Prostate Cancer
CURE Webinar on Diversity, Equity and Inclusion in Prostate Cancer
November 17, 2023
Video
In conjunction with ZERO — The End of Prostate Cancer, CURE® recently hosted the “Educated Patient® Webinar: Advancing Equity in Prostate Cancer Care.”
Treatments for Men Whose Prostate Cancer Has Spread and Become Resistant to Hormonal Therapy are Growing
September 29, 2020
Article
A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.
Smartphone App Encourages Smoking Cessation, House Passes Veteran’s Prostate Cancer Treatment and Research Act, and More
September 25, 2020
Article
From a new study showing that the iCanQuit smoking cessation app is more likely to work than typical guidelines, to the House unanimously passing the Veteran’s Prostate Cancer Treatment and Research Act, here’s what’s happening in the cancer landscape this week.
CURE® Speaking Out Launches Video Series in Recognition of National Prostate Cancer Awareness Month
September 08, 2020
Article
Charles J. Ryan, M.D., internationally recognized for his research on prostate cancer, discusses risk factors, treatments and racial disparities associated with the disease.